QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSE:TBI

TrueBlue (TBI) Stock Forecast, Price & News

$17.94
-0.32 (-1.75%)
(As of 06/9/2023 ET)
Compare
Today's Range
$17.80
$18.14
50-Day Range
$14.98
$18.53
52-Week Range
$14.20
$22.75
Volume
242,985 shs
Average Volume
204,654 shs
Market Capitalization
$556.50 million
P/E Ratio
12.55
Dividend Yield
N/A
Price Target
$20.00

TrueBlue MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
11.7% Upside
$20.00 Price Target
Short Interest
Healthy
1.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$75,000 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Business Services Sector

282nd out of 330 stocks

Help Supply Services Industry

16th out of 17 stocks


TBI stock logo

About TrueBlue (NYSE:TBI) Stock

TrueBlue, Inc. engages in the provision of staffing, recruitment process outsourcing and managed service provider solutions. It operates through the following segments: PeopleReady, PeopleManagement and PeopleScout. The PeopleReady segment offers staffing solutions for blue-collar, contingent on-demand and skilled labor to a broad range of industries that include retail, manufacturing, warehousing, logistics, energy, construction, hospitality and others. The PeopleManagement segment supplies contingent labor and outsourced industrial workforce solutions. The PeopleScout segment covers the provision of permanent employee recruitment process outsourcing for its customers for all major industries and jobs. The company was founded by John Ross Coghlan and Glenn Welstad in 1989 and is headquartered in Tacoma, WA.

Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

TBI Stock News Headlines

TrueBlue (NYSE:TBI) Lifted to "Buy" at StockNews.com
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
TrueBlue (NYSE:TBI) Rating Increased to Buy at StockNews.com
PeopleReady Revs Up Staffing for Indy500
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
TrueBlue (NYSE:TBI) Lowered to Hold at StockNews.com
TrueBlue (NYSE:TBI) PT Lowered to $18.00 at BMO Capital Markets
Q1 2023 TrueBlue Inc Earnings Call
Robert W. Baird Cuts TrueBlue (NYSE:TBI) Price Target to $20.00
TrueBlue Reports First Quarter 2023 Results
Earnings Preview: TrueBlue
TrueBlue (NYSE:TBI) Downgraded to "Hold" at StockNews.com
TrueBlue (TBI) Scheduled to Post Quarterly Earnings on Monday
Staff Management | SMX Celebrates 35th Anniversary
See More Headlines

TBI Price History

TBI Company Calendar

Last Earnings
4/24/2023
Today
6/09/2023
Next Earnings (Estimated)
7/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
6,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$20.00
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+11.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$62.27 million
Pretax Margin
2.58%

Debt

Sales & Book Value

Annual Sales
$2.25 billion
Cash Flow
$3.27 per share
Book Value
$15.17 per share

Miscellaneous

Free Float
29,782,000
Market Cap
$556.50 million
Optionable
Optionable
Beta
1.44

Key Executives

  • Steven C. Cooper
    Chief Executive Officer & Director
  • Taryn R. OwenTaryn R. Owen
    President & Chief Operating Officer
  • Derrek L. GaffordDerrek L. Gafford
    Chief Financial Officer & Executive Vice President
  • Jeffrey S. Dirks
    Chief Information & Technology Officer
  • Garrett R. Ferencz
    Executive Vice President & General Counsel













TBI Stock - Frequently Asked Questions

Should I buy or sell TrueBlue stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" TBI shares.
View TBI analyst ratings
or view top-rated stocks.

What is TrueBlue's stock price forecast for 2023?

1 brokers have issued 12-month price targets for TrueBlue's shares. Their TBI share price forecasts range from $20.00 to $20.00. On average, they predict the company's stock price to reach $20.00 in the next year. This suggests a possible upside of 11.5% from the stock's current price.
View analysts price targets for TBI
or view top-rated stocks among Wall Street analysts.

How have TBI shares performed in 2023?

TrueBlue's stock was trading at $19.58 on January 1st, 2023. Since then, TBI shares have decreased by 8.4% and is now trading at $17.94.
View the best growth stocks for 2023 here
.

Are investors shorting TrueBlue?

TrueBlue saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 581,700 shares, an increase of 21.2% from the April 30th total of 480,000 shares. Based on an average daily volume of 229,500 shares, the short-interest ratio is presently 2.5 days. Approximately 2.0% of the shares of the stock are sold short.
View TrueBlue's Short Interest
.

When is TrueBlue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 24th 2023.
View our TBI earnings forecast
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) released its quarterly earnings results on Monday, April, 24th. The business services provider reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.05. The business services provider earned $465.29 million during the quarter, compared to analyst estimates of $465.30 million. TrueBlue had a trailing twelve-month return on equity of 13.39% and a net margin of 2.19%. The company's quarterly revenue was down 15.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.44 earnings per share.

What guidance has TrueBlue issued on next quarter's earnings?

TrueBlue updated its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $487.00 million-$512.00 million, compared to the consensus revenue estimate of $488.95 million.

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

What is TrueBlue's stock symbol?

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (17.96%), Pzena Investment Management LLC (8.30%), Hotchkis & Wiley Capital Management LLC (8.09%), Dimensional Fund Advisors LP (7.91%), State Street Corp (4.20%) and Charles Schwab Investment Management Inc. (2.44%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Garrett Ferencz, Kristy A Fitzsimmons-Willis, Richard Christensen, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends
.

How do I buy shares of TrueBlue?

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TrueBlue's stock price today?

One share of TBI stock can currently be purchased for approximately $17.94.

How much money does TrueBlue make?

TrueBlue (NYSE:TBI) has a market capitalization of $556.50 million and generates $2.25 billion in revenue each year. The business services provider earns $62.27 million in net income (profit) each year or $1.43 on an earnings per share basis.

How many employees does TrueBlue have?

The company employs 6,500 workers across the globe.

How can I contact TrueBlue?

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The official website for the company is www.trueblue.com. The business services provider can be reached via phone at (253) 383-9101, via email at investorrelations@trueblueinc.com, or via fax at 877-733-0399.

This page (NYSE:TBI) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -